Adults with lymphoma treated with CAR T therapy
Adults with lymphoma treated with CAR T therapy at King’s College Hospital. The hospital in south London has become the first in the UK...
What is diabetes? Symptoms, policy and treatment
Diabetes is a serious health condition and there are two main types: Type 1 and Type 2. How do they differ and what treatments are available? Diabetes...
The key to engaging healthcare professionals effectively
Hank Sczerba on how to understand healthcare professionals in order to target them more effectively
Tell me about yourself and what you do? I am Head...
Supporting First Line Field Managers in Pharma
Ian Robinson discusses how to provide structure to sequential in-call coaching to enhance customer excellence when supporting First Line Field Managers in pharma. In the...
What will 2D matrix coding achieve for the pharma industry?
Tony Cordrey is Vice President of European Strategic Operations at Accord Healthcare. Having been at the forefront of the Falsified Medicines Directive (FMD) rollout,...
Antimicrobial resistance: Innovation must go hand-in-hand with awareness
Paul Chapman discusses antimicrobial resistance and how innovation must go hand-in-hand with awareness to combat superbugs. A recent study from researchers at Glasgow Caledonian University warned...
Pf Awards 2019: A Bright Future
Shannon Travers won the Best Newcomer Award at the Pf Awards 2019. Here she responds to her win, shares insights into her career and...
Transition and transformation in the pharmaceutical industry
Ben Osborn, Managing Director of Pfizer UK, talks transition and transformation in the pharmaceutical industry. Ben Osborn is the recently appointed Managing Director of Pfizer...
The use of LinkedIn and the ABPI Code of Practice
Rina Newton, Managing Director of CompliMed, offers guidance on the use of LinkedIn and the ABPI Code of Practice. The Prescription Medicines Code of Practice Authority...
Does health trust pharma? The results
Pf Magazine, along with E4H, set out to survey healthcare professionals about the level of trust they have in the pharmaceutical industry. This is...
